X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The idea has widespread and bipartisan support: A bill passed unanimously in the Senate last August, and 38 states have enacted their own versions. (Photo: Shutterstock)

During his first State of the Union Address, U.S. President Donald Trump endorsed a proposed national “Right to Try” law, which aims to make it easier for terminally ill patients to get access to experimental drugs. The idea has widespread and bipartisan support: A bill passed unanimously in the Senate last August, and 38 states have enacted their own versions. However, some physicians and medical ethicists, as well as the drug industry, oppose such legislation, arguing that it’s unnecessary and not in the best interests of patients or the general public. 

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.